Article
Drug development advances in human genetics‐based targets
1 Feb 2024
Abstract excerpt
Drug development is a long and costly process, with a high degree of uncertainty from the identification of a drug target to its market launch. Targeted drugs supported by human genetic evidence are expected to enter phase II/III clinical trials or be approved for marketing more quickly, speeding up the drug development process. Currently, genetic data and technologies such as genome-wide association studies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
